1. Home
  2. LIF vs BEAM Comparison

LIF vs BEAM Comparison

Compare LIF & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Life360 Inc.

LIF

Life360 Inc.

HOLD

Current Price

$48.18

Market Cap

3.7B

Sector

N/A

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$30.78

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIF
BEAM
Founded
2008
2017
Country
United States
United States
Employees
547
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.0B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
LIF
BEAM
Price
$48.18
$30.78
Analyst Decision
Strong Buy
Buy
Analyst Count
11
12
Target Price
$75.58
$50.75
AVG Volume (30 Days)
650.0K
1.8M
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
82.31
EPS
N/A
N/A
Revenue
N/A
$24,000.00
Revenue This Year
$36.21
N/A
Revenue Next Year
$20.80
$33.77
P/E Ratio
$425.29
N/A
Revenue Growth
N/A
33.33
52 Week Low
$37.01
$15.60
52 Week High
$112.54
$36.44

Technical Indicators

Market Signals
Indicator
LIF
BEAM
Relative Strength Index (RSI) 60.49 52.91
Support Level $37.47 $26.96
Resistance Level $48.37 $33.32
Average True Range (ATR) 2.54 2.16
MACD 0.29 -0.11
Stochastic Oscillator 82.84 44.32

Price Performance

Historical Comparison
LIF
BEAM

About LIF Life360 Inc.

Life360 is the world's largest family focused social network, with nearly 100 million monthly active users. Security-conscious families use the Life360 app to track each other's whereabouts and to track the location of their pets and personal belongings. Life360 also offers a suite of additional security features, such as driver safety monitoring, roadside assistance, and emergency dispatching. In the US, the Life360 app regularly ranks in the top 10 most popular social-networking apps and in the top 25 across all apps in terms of daily active users.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Share on Social Networks: